AURELIUS European Opportunities IV

AURELIUS European Opportunities IV was raised in 2021 to invest in UK and European midmarket companies with operational value creation and development potential. The Fund has secured EUR 380 million of total commitments from a diverse group of institutional investors, including US and European university endowments, pension funds, insurance companies, as well as family offices. As co-investor, AURELIUS Equity Opportunities SE & Co. KGaA has committed up to EUR 160 million. Accordingly, total commitments available to invest amount to EUR 540 million.


AURELIUS European Opportunities IV targets corporate carve-outs, platform build-ups and complex buy-out situations with EUR 100 million revenues or greater. A core differentiator is the access to a team of 80+ in-house AURELIUS Operating Taskforce who support our portfolio companies in their operational development and future growth

Investment Criteria


We focus on businesses with revenues of at least EUR 100 million and with equity investment requirements of up to EUR 100 million


We seek control equity investment opportunities in businesses with development potential requiring financial and/or operational improvement


We invest in opportunities, rather than specific sectors, although we have proven capability in IT and Business Services, Industrials & Chemicals, Lifestyle & Consumer Goods


We specialise in investing in mid-market businesses, corporate carve-outs, platform build-ups and complex buy-outs


We seek businesses that are headquartered in the UK or Europe and with a sizeable part of their operations in Western Europe. Specifically, UK & Ireland, DACH (Germany, Austria, Switzerland), Benelux (Belgium, Netherlands, Luxemburg), Nordics (Denmark, Finland, Iceland, Norway, Sweden), Southern Europe (Spain, Northern Italy) and Central & Eastern Europe. Many of our previous investments also had operations in the Middle East, Africa, Asia and North America


We will target businesses that operate in stable or growing markets or that have long-term prospects for growth


TM Group

TM Group is a leading provider of property search aggregation services, suppling law firms with property searches, a key element of due diligence for all property purchases in the UK.

» Website


ECO3 (formerly Agfa Offset Solutions) is a leading global supplier of prepress systems to the printing industry. Commercial, newspaper and packaging printers rely on us for the most extensive range of integrated solutions, from printing plates and computer-to-plate systems over workflow and print management software to pressroom chemicals. The company is commercially active in more than 75 countries worldwide, reached a market leading position in Europe and LATAM and ranks among the top players in other markets. AURELIUS European Opportunities IV, S.C.A. SICAV-RAIF and AURELIUS Equity Opportunities SE & Co. KGaA as co-investor jointly acquired EOC3 from the Agfa-Gevaert Group in 2023. *

» Website

Advanced Power Solutions

Advanced Power Solutions (formerly Panasonic’s European Consumer Battery Business) is one of the leading producers in the European batteries market. The company’s key products include alkaline and zinc-carbon batteries, rechargeable Ni-MH batteries and specialty batteries. Advanced Power Solutions sells its products under the Panasonic and eneloop brands. It also makes products for private-label brands and original equipment manufacturers, which enables the company to maintain a continuously high level of capacity utilization. AURELIUS European Opportunities IV and AURELIUS Equity Opportunities SE & Co. KGaA as co-investor jointly acquired the business from Panasonic in 2021.


Enerveo (formerly SSE Contracting Limited) is a leading multi-disciplinary contracting business. The business operates across a network with over 60 locations throughout the UK & Ireland providing mechanical, electrical, lighting, electric vehicle (EV), rail and high voltage engineering services to install and maintain key infrastructure. Enerveo also maintains over one million street lights, making it the largest street lighting contractor in the UK. The company employs c. 1,900 people across the UK & Ireland

» Website


Headquartered in London, Minova Group is a global manufacturer of ground-control products to mining and infrastructure customers. The business has a heritage of over 140‐years of developing and delivering innovative ground support solutions. Minova is among the Top-3 in all relevant markets with 13 production sites and 18 sales offices across North America, Europe, South Africa, India, and Australia. The company has more than 1,000 employees. AURELIUS European Opportunities IV, S.C.A. SICAV-RAIF and AURELIUS Equity Opportunities SE & Co. KGaA as co-investor jointly acquired Minova from Orica in 2022.*

Ceramic Tile Distributors

Ceramic Tile Distributors  is a UK-based specialist supplier of high-quality ceramic tiles operating 89 branches and 4 trading distribution hubs. The business sells tiles, tile adhesives, grout as well as associated tools and consumables for the preparation, laying, cutting and drilling of tiles. With over 50 years of experience, Ceramic Tile Distributors has a leading B2B market position in the industry. AURELIUS European Opportunities IV, S.C.A. SICAV-RAIF and AURELIUS Equity Opportunities SE & Co. KGaA as co-investor jointly acquired Ceramic Tile Distributors from Saint-Gobain in 2022.

» Website

Hallo Healthcare Group

LloydsPharmacy is the parent company of a number of market leading healthcare businesses including John Bell & Croyden and AAH Pharmaceuticals. The business operates across four divisions: retail, digital, homecare and wholesale. LloydsPharmacy provides pharmaceutical prescriptions, over the counter medicines and other healthcare services through c.1,400 retail pharmacies and c.40 outpatient hospital sites. LloydsDirect is a digital pharmaceutical prescriptions and over the counter medicines pharmacy. LloydsPharmacy Clinical Homecare is a leading provider of health products and services from delivery of medication to specialist nursing in patients’ homes. AAH Pharmaceuticals is a major pharmaceutical wholesaler, distributing medicines and health products to NHS hospitals and pharmacies. The group has over 18,000 employees, including pharmacists, nurses, logistics operatives as well as store, warehouse and administration personnel.

» Website

dental bauer and Pluradent

AURELIUS European Opportunities IV, S.C.A. SICAV-RAIF and AURELIUS Equity Opportunities SE & Co. KGaA as co-investor jointly acquired, in a combined transaction, two leading dental depots in the DACH region – dental bauer and Pluradent. The newly combined group now ranks among the top dental depot suppliers in its region. The transaction took place in 2022.
dental bauer is one of the leading dental depots in the DACH region and the Netherlands. Founded in 1947, the family-run business offers consumable materials, capital equipment and devices, and technical and consulting services to dental practices and laboratories. dental bauer has been growing for many years through a lean and flexible organization, the establishment of new branches and locations, and through smaller and larger acquisitions within the industry.
Pluradent, headquartered in Offenbach am Main, is a well-known German dental distributor, supplying dental facilities with consumable materials, equipment and devices, and technical services. The group also operates subsidiaries in Austria and Poland and an own distribution center in Kassel, Germany. After the company had been facing financial distress during the COVID pandemic, insolvency proceedings were opened recently. *


Footasylum is an omni-channel retailer of fashion streetwear and sportswear with 63 stores across the UK. The company was founded in 2005 and is headquartered in Rochdale, UK. Footasylum comprises seven websites (group and own brand sites) and warehouse facilities. Today, the business sells a mix of footwear, apparel and accessories through stores, websites, and a wholesale channel. AURELIUS European Opportunities IV and AURELIUS Equity Opportunities SE & Co. KGaA as co-investor jointly acquired Footasylum from JD Sports in 2022.*

» Website

*) This information is correct at the time of publication


Aurelius European Opportunities GP S.à r.l.

Fabian Steger
Managing Director
2-4, rue du Chateau d’Eau - L-3364 Leudelange 

T: +352 2021 10 78 70

Aurelius Investment Advisory Limited

Tristan Nagler
6th Floor, 33 Glasshouse Street, London W1B 5DG
United Kingdom

T: +44 (0)20 7440 0485

Legal Information

The information on this website is for informational purposes only. The information on this website is not, and is not intended to be, investment advice nor is it a recommendation to enter into any investment; investors should seek independent investment advice before making any investment decisions. The information on this website does not constitute an offer to buy or sell any investment product or service or to engage in any investment activity, or a solicitation of any investment product or service in any jurisdiction in which Aurelius is not permitted to provide its services or make available any investment product.

Any investment opportunities that Aurelius makes available from time to time will only be available to professional investors and will be subject to separate terms and conditions which will apply. This website and the contents herein are only available to such investors in jurisdictions where Aurelius is permitted to offer its products or services. No other person may rely on the information contained in this website.

For UK recipients

This website has been communicated by Aurelius Investment Advisory Limited (“Aurelius”), an authorised representative for its principal Mirabella Advisers LLP, which is authorized and regulated by the Financial Conduct Authority, FCA FRN 606792.

This website is directed at only those entities who are investment professionals with professional experience in matters relating to the contents of this website or other persons who would be classified as professional investors or eligible counterparties pursuant to the rules of the Financial Conduct Authority. In particular, this website is not available to, and may not be relied on by, any person who is a retail investor. If you are in any doubt as to whether you would be deemed to be a retail investor, please seek professional advice and refrain from accessing this website until such advice has been received.